Biography
Hans Desale is a doctoral candidate in the Department of Tropical Medicine at the Tulane University School of Public Health and Tropical Medicine, working in the lab of Dr. Eric Dumonteil and Dr. Claudia Herrera focused on the research and control of Chagas Disease.
Research interests include one health, implementation science, and genetic epidemiology to better understand parasitic and vector-borne diseases.
Hans received his Master of Public Health and Tropical Medicine degree from Tulane University in 2018 after completing his Bachelor in Science in biochemistry from the University of California, San Diego in 2009. Hans has worked in a variety of public health settings worldwide, including autoimmune drug discovery, avian flu research and endangered animal breeding/release at the San Diego Zoo, improving medical access in rural India, monitoring and evaluation in Rwanda, modeling dengue virus transmission in Honduras, lab capacity building in Ethiopia, and understanding Zika virus transmission in Louisiana, USA.
Honors & Awards
- 2022: Excellence in Research and Presentation by a Public Health Doctoral Student, Tulane Health Science Research Days
- 2021: Student Poster Competition Winner, American Association of Veterinary Parasitology
- 2018: Charles C Bass Award Outstanding Student in Tropical Medicine, Tulane University
Publications
Epigenetic signature of exposure to maternal Trypanosoma cruzi infection in cord blood cells from uninfected newborns. Desale H, Buekens P, Alger J, Cafferata ML, Harville EW, Herrera C, Truyens C, Dumonteil E. Epigenomics. 2022 Aug 29. Epub ahead of print
Shelter cats host infections with multiple Trypanosoma cruzi discrete typing units in southern Louisiana. Dumonteil, E., Desale, H., Tu, W., Duhon, B., Wolfson, W., Balsamo, G., & Herrera, C. (2021). Veterinary research, 52(1), 53.
Using Prenatal Blood Samples to Evaluate COVID-19 Rapid Serologic Tests Specificity. Alger J, Cafferata ML, Alvarado T, Ciganda A, Corrales A, Desale H, Drouin A, Fusco D, Garcia J, Gibbons L, Harville E, Lopez W, Lorenzana I, Muñoz-Lara F, Palou E, Retes E, Sierra M, Stella C, Xiong X, Zambrano LI, Buekens P. Matern Child Health J. 2020 Sep;24(9):1099-1103. doi: 10.1007/s10995-020-02981-9.
Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity. Scott FL, Clemons B, Brooks J, Brahmachary E, Powell R, Dedman H, Desale HG, Timony GA, Martinborough E, Rosen H, Roberts E, Boehm MF, Peach RJ. Br J Pharmacol. 2016 Jun;173(11):1778-92. doi: 10.1111/bph.13476. Epub 2016 Apr 28.
Crystal structure of a lipid G protein-coupled receptor. Hanson MA, Roth CB, Jo E, Griffith MT, Scott FL, Reinhart G, Desale H, Clemons B, Cahalan SM, Schuerer SC, Sanna MG, Han GW, Kuhn P, Rosen H, Stevens RC. Science. 2012 Feb 17;335(6070):851-5. doi: 10.1126/science.1215904. PMID: 22344443 PMID: 26990079
Dissertation Info
Investigating the mechanisms of pathogenesis from T. cruzi infection
